Company attributes
B2X
0
Number of Employees (Ranges)
201 – 5000
Place of Incorporation
Investors
Founded Date
2015
0Total Funding Amount (USD)
120,000,000
Latest Funding Round Date
May 28, 2019
Competitors
Stock Symbol
9966.HK
Exchange
Latest Funding Type
Country
Headquarters
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
60,000,000
Alphamab combines antibody discovery platforms and GMP manufacturing expertise to its pipeline of nanobodies, bispecifics and multi-antibody cocktails.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
